Liemei Guo

1.1k total citations
39 papers, 790 citations indexed

About

Liemei Guo is a scholar working on Neurology, Cancer Research and Molecular Biology. According to data from OpenAlex, Liemei Guo has authored 39 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Neurology, 12 papers in Cancer Research and 9 papers in Molecular Biology. Recurrent topics in Liemei Guo's work include Intracranial Aneurysms: Treatment and Complications (9 papers), Cancer-related molecular mechanisms research (8 papers) and MicroRNA in disease regulation (7 papers). Liemei Guo is often cited by papers focused on Intracranial Aneurysms: Treatment and Complications (9 papers), Cancer-related molecular mechanisms research (8 papers) and MicroRNA in disease regulation (7 papers). Liemei Guo collaborates with scholars based in China, United States and Finland. Liemei Guo's co-authors include Yongming Qiu, Xiaohua Zhang, Yingying Lin, Jianwei Ge, Rogelio Medina, Jing Cui, Hongyu Zhou, Weizhen Gao, Jiwen Xu and Jiyao Jiang and has published in prestigious journals such as Experimental Cell Research, Behavioural Brain Research and Drug and Alcohol Dependence.

In The Last Decade

Liemei Guo

38 papers receiving 780 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liemei Guo China 14 348 272 174 147 100 39 790
Jordan Jones Australia 14 452 1.3× 149 0.5× 119 0.7× 44 0.3× 152 1.5× 31 923
Jenny Kan-Suen Pu Hong Kong 15 339 1.0× 307 1.1× 164 0.9× 35 0.2× 109 1.1× 24 742
Takafumi Ide Japan 14 281 0.8× 119 0.4× 256 1.5× 60 0.4× 237 2.4× 33 797
Hajime Kamada Japan 15 316 0.9× 83 0.3× 72 0.4× 163 1.1× 96 1.0× 41 703
Jinsen Zhang China 15 375 1.1× 249 0.9× 75 0.4× 151 1.0× 192 1.9× 37 888
Mingxuan Xu United States 11 156 0.4× 134 0.5× 63 0.4× 97 0.7× 99 1.0× 24 555
Michael Tobias United States 12 320 0.9× 96 0.4× 171 1.0× 96 0.7× 223 2.2× 30 777
Ali Jalali United States 12 302 0.9× 117 0.4× 92 0.5× 57 0.4× 102 1.0× 40 602
Shunji Yunoue Japan 16 237 0.7× 69 0.3× 175 1.0× 88 0.6× 190 1.9× 26 733
Kazuhito Matsuzaki Japan 19 363 1.0× 120 0.4× 341 2.0× 105 0.7× 141 1.4× 43 942

Countries citing papers authored by Liemei Guo

Since Specialization
Citations

This map shows the geographic impact of Liemei Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liemei Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liemei Guo more than expected).

Fields of papers citing papers by Liemei Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liemei Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liemei Guo. The network helps show where Liemei Guo may publish in the future.

Co-authorship network of co-authors of Liemei Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Liemei Guo. A scholar is included among the top collaborators of Liemei Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liemei Guo. Liemei Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Liemei, Mei Xin, Yunlan Du, et al.. (2025). PRKN/PINK1 Mutations in a Chinese Patient With Early‐Onset Parkinson's Disease. Brain and Behavior. 15(9). e70822–e70822. 2 indexed citations
3.
Guo, Liemei, Jing Cui, Herui Wang, et al.. (2020). Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways. Molecular Therapy — Oncolytics. 20. 119–131. 45 indexed citations
4.
Liao, Keman, Yingying Lin, Weizhen Gao, et al.. (2019). Blocking lncRNA MALAT1/miR-199a/ZHX1 Axis Inhibits Glioblastoma Proliferation and Progression. Molecular Therapy — Nucleic Acids. 18. 388–399. 85 indexed citations
5.
Gao, Weizhen, et al.. (2018). Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients. Journal of Translational Medicine. 16(1). 368–368. 48 indexed citations
6.
Guo, Liemei, Chen Xu, Bin Yu, Lin Shen, & Xiaohua Zhang. (2017). Delayed Intracerebral Hemorrhage Secondary to Ventriculoperitoneal Shunt: A Retrospective Study. World Neurosurgery. 107. 160–167. 7 indexed citations
7.
Zhao, Hongyan, et al.. (2016). Posttraumatic Intradiploic Pseudomeningocele of the Occipito-Cervical Region. Journal of Craniofacial Surgery. 28(2). e152–e154. 1 indexed citations
8.
Li, Yang, et al.. (2016). Primary Spinal Oligoastrocytoma. Journal of Craniofacial Surgery. 27(3). e311–e313.
9.
Yang, Xi, Jun Tong, Liemei Guo, et al.. (2016). Bundling potent natural toxin cantharidin within platinum (IV) prodrugs for liposome drug delivery and effective malignant neuroblastoma treatment. Nanomedicine Nanotechnology Biology and Medicine. 13(1). 287–296. 17 indexed citations
10.
An, Yanyan, et al.. (2016). The Coexistence of Rathke Cleft Cyst and Pituitary Adenoma. Journal of Craniofacial Surgery. 27(2). e128–e130. 6 indexed citations
11.
Shu, Hansheng, et al.. (2015). Intracranial Hemorrhage due to Rupture of an Anterior Communicating Artery Aneurysm in a Patient With Pituitary Adenoma. Journal of Craniofacial Surgery. 26(2). e154–e155. 2 indexed citations
12.
Nie, Quanmin, Guo Pin, Liemei Guo, et al.. (2015). Overexpression of isocitrate dehydrogenase-1R132H enhances the proliferation of A172 glioma cells via aerobic glycolysis. Molecular Medicine Reports. 11(5). 3715–3721. 8 indexed citations
13.
Guo, Liemei, Xi Yang, Xinjian Lin, et al.. (2015). Silencing of Id2 attenuates hypoxia/ischemia-induced neuronal injury via inhibition of neuronal apoptosis. Behavioural Brain Research. 292. 528–536. 13 indexed citations
14.
Wang, Hao, et al.. (2015). Chondromyxoid Fibroma of the Frontal Bone Mimicking Meningioma. Journal of Craniofacial Surgery. 26(2). e179–e181. 3 indexed citations
15.
Zhong, Yumin, Quanmin Nie, Weibo Chen, et al.. (2015). Feasibility of three-dimensional ultrashort echo time magnetic resonance imaging at 1.5 T for the diagnosis of skull fractures. European Radiology. 26(1). 138–146. 11 indexed citations
16.
Zhao, Hongyan, et al.. (2014). Duret Hemorrhage After Lumbar Drainage. Journal of Craniofacial Surgery. 25(4). 1551–1552. 11 indexed citations
17.
Wu, Hui, et al.. (2014). Cavernous Internal Carotid Artery Aneurysm After Radiotherapy Presenting With External Ophthalmoplegia. Journal of Craniofacial Surgery. 25(4). e380–e382. 5 indexed citations
18.
Guo, Liemei, Lan Jin, Yingying Lin, et al.. (2013). Hypoxia/ischemia up-regulates Id2 expression in neuronal cells in vivo and in vitro. Neuroscience Letters. 554. 88–93. 11 indexed citations
19.
Pin, Guo, Lan Jin, Jianwei Ge, et al.. (2013). MiR-26a enhances the radiosensitivity of glioblastoma multiforme cells through targeting of ataxia–telangiectasia mutated. Experimental Cell Research. 320(2). 200–208. 53 indexed citations
20.
Guo, Liemei, Hongyu Zhou, Jiwen Xu, et al.. (2011). Risk Factors Related to Aneurysmal Rebleeding. World Neurosurgery. 76(3-4). 292–298. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026